Skip to main content
. 2021 May 28;16(5):e0252621. doi: 10.1371/journal.pone.0252621

Fig 1. Result comparison of 107 paired DBS and serum samples analyzed for IgG against the SARS-CoV-2 nucleocapsid (NC, panel A), spike glycoprotein S1 subunit (S1, panel B) and receptor binding domain (RBD) antigens (panel C) using the Luminex xMAP assay.

Fig 1

The samples represented by the X and the diamond indicate two cases with discordant result interpretations.